Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Jonathan G. Drachman | Director | $77.2K | Nov 10, 2021 | ||
Francesco Parlati | Sr. Vp, Research | $54.4K | Jan 25, 2022 | ||
Susan Molineaux | PRESIDENT & CEO, Director | $14.6K | Jan 23, 2023 | ||
Christopher Molineaux | Sr. Vp, Development | $14.6K | Jan 23, 2023 | ||
Eric Sjogren | Sr. Vp, Drug Discovery | $3.27K | Jan 23, 2023 | ||
Stephanie Wong | Chief Financial Officer & Secretary | $2.56K | Jan 23, 2023 | ||
Emil Kuriakose | Chief Medical Officer | $1.37K | Jan 23, 2023 | ||
Sumita Ray | Svp, General Counsel & Chief Compliance Officer | Jan 25, 2022 | |||
Keith Orford | Director | Jun 1, 2022 | |||
Takeda Pharmaceutical Co Ltd | Former 10% Owner | Apr 17, 2023 | |||
Ward Wolff | Director | Jun 1, 2022 | |||
Deepika Pakianathan | Director | Jan 27, 2023 | |||
Sunil Agarwal | Director | Jun 1, 2022 | |||
Jean George | Director | Jun 11, 2021 | |||
Suzy Jones | Director | Jun 1, 2022 | |||
J. Scott Garland | Director | Jun 1, 2022 | |||
Blake Wise | Director | Jun 1, 2022 |
Insider | Symbol | Class | Transaction | % | Value $ | Price $ | Shares | Shares Owned | Date | Ownership |
---|